Viking Therapeutics Ord Shs (VKTX)
$6.88 0.00 (0.00%)
19:50 EDT VKTX Stock Quote Delayed 30 Minutes
Previous Close $6.88
Market Cap 409.76M
PE Ratio -10.42
Volume (Avg. Vol.)
Day's Range 6.88 - 6.88
52-Week Range 3.26 - 8.87
Dividend & Yield N/A (N/A)
VKTX Stock Predictions, Articles, and Viking Therapeutics Ord Shs News
- From InvestorPlace
- From the Web
Viking Therapeutics stock got a boost from Gilead's failure earlier this week, but does that make VKTX stock a buy? Let's look.
Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.
Viking Therapeutics (VKTX) stock was entering orbit on Tuesday after releasing results from a recent study concerning fatty liver treatment.
Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk. Here are five to buy today.
Biotech's luck is changing as the trend looks to be upward and outward for the biotech stocks. These are the five to watch.
From Market News Video
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component BJ's Wholesale Club Holdings Inc (BJ) was identified as having a larger market cap than the smaller end of the S&P 500, for example Apache Corp (APA), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Market capitalization is an important data point for investors to keep an eye on, for various reasons..
Navellier RatingsPowered by Portfolio Grader